Cargando…
Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5
CCR5 stimulation with natural ligands, such as RANTES, classically induces short-term internalization with transient activation of β-arrestins and rapidly recycling on the cell surface. Here we discovered that, in T cells, natural CCR5 antibodies induce a CCR5-negative phenotype with the involvement...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180096/ https://www.ncbi.nlm.nih.gov/pubmed/28008933 http://dx.doi.org/10.1038/srep39382 |
_version_ | 1782485461606858752 |
---|---|
author | Venuti, Assunta Pastori, Claudia Pennisi, Rosamaria Riva, Agostino Sciortino, Maria Teresa Lopalco, Lucia |
author_facet | Venuti, Assunta Pastori, Claudia Pennisi, Rosamaria Riva, Agostino Sciortino, Maria Teresa Lopalco, Lucia |
author_sort | Venuti, Assunta |
collection | PubMed |
description | CCR5 stimulation with natural ligands, such as RANTES, classically induces short-term internalization with transient activation of β-arrestins and rapidly recycling on the cell surface. Here we discovered that, in T cells, natural CCR5 antibodies induce a CCR5-negative phenotype with the involvement of β-arrestin2, which leads to the formation of a stable CCR5 signalosome with both β-arrestin2 and ERK1. The activation of β-arrestin2 is necessary to CCR5 signaling for the signalosome formation and stabilization. When all stimuli were washed out, β-arrestin1 silencing favors the activity of β-arrestin2 for the CCR5 signalosome retention. Interestingly, CCR5 turn from Class A trafficking pattern, normally used for its internalization with natural modulating molecules (i.e. RANTES), into a long lasting Class B type specifically induced by stimulation with natural anti-CCR5 antibodies. This new CCR5 pathway is relevant not only to study in depth the molecular basis of all pathologies where CCR5 is involved but also to generate new antidody-based therapeutics. |
format | Online Article Text |
id | pubmed-5180096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51800962016-12-29 Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5 Venuti, Assunta Pastori, Claudia Pennisi, Rosamaria Riva, Agostino Sciortino, Maria Teresa Lopalco, Lucia Sci Rep Article CCR5 stimulation with natural ligands, such as RANTES, classically induces short-term internalization with transient activation of β-arrestins and rapidly recycling on the cell surface. Here we discovered that, in T cells, natural CCR5 antibodies induce a CCR5-negative phenotype with the involvement of β-arrestin2, which leads to the formation of a stable CCR5 signalosome with both β-arrestin2 and ERK1. The activation of β-arrestin2 is necessary to CCR5 signaling for the signalosome formation and stabilization. When all stimuli were washed out, β-arrestin1 silencing favors the activity of β-arrestin2 for the CCR5 signalosome retention. Interestingly, CCR5 turn from Class A trafficking pattern, normally used for its internalization with natural modulating molecules (i.e. RANTES), into a long lasting Class B type specifically induced by stimulation with natural anti-CCR5 antibodies. This new CCR5 pathway is relevant not only to study in depth the molecular basis of all pathologies where CCR5 is involved but also to generate new antidody-based therapeutics. Nature Publishing Group 2016-12-23 /pmc/articles/PMC5180096/ /pubmed/28008933 http://dx.doi.org/10.1038/srep39382 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Venuti, Assunta Pastori, Claudia Pennisi, Rosamaria Riva, Agostino Sciortino, Maria Teresa Lopalco, Lucia Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5 |
title | Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5 |
title_full | Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5 |
title_fullStr | Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5 |
title_full_unstemmed | Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5 |
title_short | Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5 |
title_sort | class b β-arrestin2-dependent ccr5 signalosome retention with natural antibodies to ccr5 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180096/ https://www.ncbi.nlm.nih.gov/pubmed/28008933 http://dx.doi.org/10.1038/srep39382 |
work_keys_str_mv | AT venutiassunta classbbarrestin2dependentccr5signalosomeretentionwithnaturalantibodiestoccr5 AT pastoriclaudia classbbarrestin2dependentccr5signalosomeretentionwithnaturalantibodiestoccr5 AT pennisirosamaria classbbarrestin2dependentccr5signalosomeretentionwithnaturalantibodiestoccr5 AT rivaagostino classbbarrestin2dependentccr5signalosomeretentionwithnaturalantibodiestoccr5 AT sciortinomariateresa classbbarrestin2dependentccr5signalosomeretentionwithnaturalantibodiestoccr5 AT lopalcolucia classbbarrestin2dependentccr5signalosomeretentionwithnaturalantibodiestoccr5 |